Oracle Siebel Life Sciences 8.1.1/8.2.2 Clinical Trip Report information disclosure

CVSS Meta Temp Score
CVSS is a standardized scoring system to determine possibilities of attacks. The Temp Score considers temporal factors like disclosure, exploit and countermeasures. The unique Meta Score calculates the average score of different sources to provide a normalized scoring system.
Current Exploit Price (≈)
Our analysts are monitoring exploit markets and are in contact with vulnerability brokers. The range indicates the observed or calculated exploit price to be seen on exploit markets. A good indicator to understand the monetary effort required for and the popularity of an attack.
CTI Interest Score
Our Cyber Threat Intelligence team is monitoring different web sites, mailing lists, exploit markets and social media networks. The CTI Interest Score identifies the interest of attackers and the security community for this specific vulnerability in real-time. A high score indicates an elevated risk to be targeted for this vulnerability.
3.8$0-$5k0.00

Summaryinfo

A vulnerability was found in Oracle Siebel Life Sciences 8.1.1/8.2.2. It has been classified as problematic. This vulnerability affects unknown code of the component Clinical Trip Report. This manipulation causes information disclosure. This vulnerability is handled as CVE-2015-0398. There is not any exploit available. Upgrading the affected component is recommended.

Detailsinfo

A vulnerability was found in Oracle Siebel Life Sciences 8.1.1/8.2.2 (Customer Relationship Management System). It has been declared as problematic. Affected by this vulnerability is an unknown code block of the component Clinical Trip Report. The manipulation with an unknown input leads to a information disclosure vulnerability. The CWE definition for the vulnerability is CWE-200. The product exposes sensitive information to an actor that is not explicitly authorized to have access to that information. As an impact it is known to affect confidentiality. The summary by CVE is:

Unspecified vulnerability in the Siebel Life Sciences component in Oracle Siebel CRM 8.1.1 and 8.2.2 allows remote authenticated users to affect confidentiality via unknown vectors related to Clinical Trip Report.

The weakness was released 01/20/2015 as Oracle Critical Patch Update Advisory - January 2015 as confirmed advisory (Website). It is possible to read the advisory at oracle.com. This vulnerability is known as CVE-2015-0398 since 12/17/2014. The exploitation appears to be easy. The attack can be launched remotely. The requirement for exploitation is a single authentication. The technical details are unknown and an exploit is not publicly available. The attack technique deployed by this issue is T1592 according to MITRE ATT&CK.

Upgrading eliminates this vulnerability. A possible mitigation has been published immediately after the disclosure of the vulnerability.

The vulnerability is also documented in the databases at X-Force (100129), SecurityFocus (BID 72207†) and Vulnerability Center (SBV-49832†). Additional details are provided at blogs.oracle.com. Entries connected to this vulnerability are available at VDB-27, VDB-68712, VDB-68703 and VDB-68721. Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

Productinfo

Type

Vendor

Name

Version

License

Website

CPE 2.3info

CPE 2.2info

CVSSv4info

VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv3info

VulDB Meta Base Score: 4.3
VulDB Meta Temp Score: 3.8

VulDB Base Score: 4.3
VulDB Temp Score: 3.8
VulDB Vector: 🔍
VulDB Reliability: 🔍

CVSSv2info

AVACAuCIA
💳💳💳💳💳💳
💳💳💳💳💳💳
💳💳💳💳💳💳
VectorComplexityAuthenticationConfidentialityIntegrityAvailability
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock
UnlockUnlockUnlockUnlockUnlockUnlock

VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍

NVD Base Score: 🔍

Exploitinginfo

Class: Information disclosure
CWE: CWE-200 / CWE-284 / CWE-266
CAPEC: 🔍
ATT&CK: 🔍

Physical: No
Local: No
Remote: Yes

Availability: 🔍
Status: Unproven

EPSS Score: 🔍
EPSS Percentile: 🔍

Price Prediction: 🔍
Current Price Estimation: 🔍

0-DayUnlockUnlockUnlockUnlock
TodayUnlockUnlockUnlockUnlock

Threat Intelligenceinfo

Interest: 🔍
Active Actors: 🔍
Active APT Groups: 🔍

Countermeasuresinfo

Recommended: Upgrade
Status: 🔍

Reaction Time: 🔍
0-Day Time: 🔍
Exposure Time: 🔍

Timelineinfo

12/17/2014 🔍
01/20/2015 +34 days 🔍
01/20/2015 +0 days 🔍
01/20/2015 +0 days 🔍
01/21/2015 +1 days 🔍
01/21/2015 +0 days 🔍
04/21/2015 +90 days 🔍
03/05/2022 +2510 days 🔍

Sourcesinfo

Vendor: oracle.com

Advisory: Oracle Critical Patch Update Advisory - January 2015
Status: Confirmed
Confirmation: 🔍

CVE: CVE-2015-0398 (🔍)
GCVE (CVE): GCVE-0-2015-0398
GCVE (VulDB): GCVE-100-68731
X-Force: 100129 - Oracle Siebel Applications Siebel Life Sciences information disclosure, Medium Risk
SecurityFocus: 72207
SecurityTracker: 1031578
Vulnerability Center: 49832 - [cpujan2015-1972971] Oracle Siebel CRM Remote Information Disclosure Related to Clinical Trip Report - CVE-2015-0398, Medium

Misc.: 🔍
See also: 🔍

Entryinfo

Created: 01/21/2015 11:33
Updated: 03/05/2022 08:13
Changes: 01/21/2015 11:33 (62), 06/27/2017 03:29 (2), 03/05/2022 08:13 (4)
Complete: 🔍
Cache ID: 216:38D:103

Statistical analysis made it clear that VulDB provides the best quality for vulnerability data.

Discussion

No comments yet. Languages: en.

Please log in to comment.

◂ PreviousOverviewNext ▸

Want to stay up to date on a daily basis?

Enable the mail alert feature now!